TY  - JOUR 
AU  - García González, Xandra
AU  - Cubo Delgado, Esther
AU  - Simón Vicente, Lucía
AU  - Mariscal, Natividad
AU  - Alcaraz, Raquel
AU  - Aguado, Laura
AU  - Rivadeneyra Posadas, Jéssica Jannett
AU  - Sanz Solas, Antonio
AU  - Saiz Rodríguez, Miriam
PY  - 2023
UR  - http://hdl.handle.net/10259/8832
AB  - Huntington’s disease (HD) is an autosomal dominant progressive brain disorder, caused by a pathological expansion of a CAG repeat that encodes the huntingtin gene. This genetic neurodegenerative rare disease is characterized by cognitive, motor, and...
LA  - eng
PB  - MDPI
KW  - Huntington
KW  - Pharmacogenetics
KW  - Antichoreic
KW  - Antidepressant
KW  - Antipsychotic
KW  - Sistema nervioso-Enfermedades
KW  - Nervous system-Diseases
KW  - Medicina
KW  - Medicine
KW  - Farmacología
KW  - Pharmacology
KW  - Neurología
KW  - Neurology
TI  - Pharmacogenetics in the Treatment of Huntington’s Disease: Review and Future Perspectives
DO  - 10.3390/jpm13030385
T2  - Journal of Personalized Medicine
VL  - 13
ER  -